Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma 2Primary Myelofibrosis 1Polycythemia Vera 1Nasopharyngeal Carcinoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Hereditary Sensory and Autonomic Neuropathies 1Chordoma 1Advanced Solid Tumors 1

Interventions

Injections 4Paclitaxel 2toripalimab 1tesetaxel 1sintilimab 1satraplatin 1pembrolizumab 1liposomal doxorubicin 1isophosphamide mustard 1fluzoparib 1duvelisib 1camrelizumab 1apatinib 1anlotinib 1Vinorelbine 1Sirolimus 1Saline Solution 1SKLB1028 1Radiotherapy 1Panobinostat 1Lenalidomide 1Irinotecan 1Everolimus 1Docetaxel 1Carboplatin 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Solid Tumors × Panobinostat × Clear all
NCT01159418 2011-09-13

LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors

Southern Europe New Drug Organization

Phase 1 Unknown
36 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡